Clinical Trial Update: Ketamine for Treatment Resistant Late-Life Depression [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating ketamine for treatment resistant late-life depression has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Late-life Depression
• Treatment-resistant Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Treatment Resistant Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2021-08-09